Updated 22 days ago
200 Fifth Ave - 6th Floor Waltham, MA 02451
Asahi Kasei Pharma America (AKP America) is a U.S. biotechnology company that is a wholly-owned subsidiary of Asahi Kasei Pharma Corp. Our lead product, ART 123 (recombinant human thrombomodulin alpha, marketed as Recomodulin® in Japan), is a late-stage biologic drug candidate being developed for severe sepsis with coagulopathy...
Our management team brings a unique combination of corporate development, global drug development and strategic alliance experience.
Associated domains: artisanpharma.net